Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring optimal protocols for generating and preserving glucose-responsive insulin-secreting progenitor cells derived from human pluripotent stem cells

24 Oct 2024

Abstract excerpt

Human pluripotent stem cells (hPSCs) represent an unlimited source of β-like cells for both disease modeling and cellular therapy for diabetes. Numerous protocols have been published describing the differentiation of hPSCs into β-like cells that secret insulin in response to a glucose challenge. However, among the most widely used protocols it is not clear which yield the most functional cells with reproducible...

Topics

Join the communities discussing this publication.

Diabetes and associated disorders
Diabetes Management and Research
Pancreatic function and diabetes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39486145
DOI: 10.1016/j.ejcb.2024.151464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring optimal protocols for generating and preserving glucose-responsive insulin-secreting progenitor cells derived from human pluripotent stem cellsPMID 39486145Read ↗

An arduous journey from human pluripotent stem cells to functional pancreatic β cellsSemantic proximity Read ↗

Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directionsSemantic proximity Read ↗

A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic isletsSemantic proximity Read ↗

Cryopreservation of Stem Cell–Derived β-Like Cells Enriches for Insulin-Producing Cells With Improved FunctionSemantic proximity Read ↗

High-purity stem cell-derived β-cells recapitulate key transcriptional and functional features of human isletsSemantic proximity Read ↗

Advances Toward Engineering Functionally Mature Human Pluripotent Stem Cell-Derived β CellsSemantic proximity Read ↗

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatmentSemantic proximity Read ↗

Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.Semantic proximity Read ↗

Concise Review: Pluripotent Stem Cell-Based Regenerative Applications for Failing β-Cell FunctionSemantic proximity Read ↗

Converting human pluripotent stem cells into β-cells: recent advances and future challengesSemantic proximity Read ↗

Characterization of stem-cell-derived islets during differentiation and after implantationSemantic proximity Read ↗

Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.